|
DAP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.540420E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.155600E-01 |
| Normal-vs-Stage2 |
2.679000E-01 |
| Normal-vs-Stage3 |
2.095800E-01 |
| Normal-vs-Stage4 |
2.385500E-02 |
| Stage1-vs-Stage2 |
7.009000E-01 |
| Stage1-vs-Stage3 |
4.517400E-01 |
| Stage1-vs-Stage4 |
5.080400E-02 |
| Stage2-vs-Stage3 |
7.062800E-01 |
| Stage2-vs-Stage4 |
1.207170E-01 |
| Stage3-vs-Stage4 |
3.933400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.975820E-02 |
| Normal-vs-AfricanAmerican |
7.982100E-02 |
| Normal-vs-Asian |
8.659400E-01 |
| Caucasian-vs-AfricanAmerican |
9.868000E-01 |
| Caucasian-vs-Asian |
4.431600E-01 |
| AfricanAmerican-vs-Asian |
4.051400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.482800E-01 |
| Normal-vs-Female |
1.68404999999483E-05 |
| Male-vs-Female |
6.03339999999397E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.115600E-02 |
| Normal-vs-Extreme_Weight |
5.207400E-01 |
| Normal-vs-Obese |
8.710400E-02 |
| Normal-vs-Extreme_Obese |
8.888400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.221700E-02 |
| Normal_Weight-vs-Obese |
4.939800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.368600E-01 |
| Extreme_Weight-vs-Obese |
2.544000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.696600E-01 |
| Obese-vs-Extreme_Obese |
3.761400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.113900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.911900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.054410E-01 |
| Normal-vs-Age(81-100Yrs) |
3.042400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.960000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.703600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.376700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.465400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.151360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.816590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.010000E-01 |
| Normal-VS-Type2 PRCC |
6.979400E-03 |
| Normal-VS-KIRP CIMP |
7.907600E-02 |
| Normal-VS-Unclassified PRCC |
5.580200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.117600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.007600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.112840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.809200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.630000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.514250E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.921400E-01 |
| Normal-vs-N1 |
8.204900E-03 |
| Normal-vs-N2 |
1.503990E-01 |
| N0-vs-N1 |
1.576170E-02 |
| N0-vs-N2 |
3.319700E-03 |
| N1-vs-N2 |
3.032400E-01 |
|
|
